6-Methoxyindole CAS 3189-13-7 Purity > 98.5% (HPLC) Hoobkas High Quality Featured duab

6-Methoxyindole CAS 3189-13-7 Purity > 98.5% (HPLC) Lub Hoobkas Zoo

Lus piav qhia luv luv:

Lub npe tshuaj: 6-Methoxyindole

CAS: 3189-13-7 Nr

Purity:> 98.5% (HPLC)

Cov tsos mob: Off-White Crystalline Powder

High Quality, Commercial Production

E-Mail: alvin@ruifuchem.com

Xa email rau peb

Product Detail

Yam khoom

Khoom cim npe

Nqe lus piav qhia:

Chaw tsim tshuaj paus Supply nrog High Quality, Commercial Production
Lub npe tshuaj: 6-Methoxyindole CAS: 3189-13-7

Chemical Properties:

Tshuaj npe	6-Methoxyindole hmoov
Synonyms	6-Methoxy-1H-indole;6-(Methyloxy)-1H-indole
CAS Nr	3189-13-7 ib
CAT Number	Qauv TSIS MUAJ: RF-PI1512
Tshuag xwm txheej	Nyob rau hauv Tshuag, ntau lawm Scale mus txog Tons
Molecular Formula	C9H9 Nr
Molecular Luj	147.18 Nws
Hom	Ruifu Tshuaj

Specifications:

Yam khoom	Specifications
Qhov tshwm sim	Off-White Crystalline Powder
Purity / Analysis Method	> 98.5% (HPLC)
Melting Point	89.0 ~ 94.0 ℃
Poob rau ziab	≤0.50%
Tag nrho cov impurities	<1.50%
Infrared Spectrum	Raws li tus qauv
Test Standard	Enterprise Standard
Kev siv	Pharmaceutical Intermediates

Pob & Cia:

Pob: Lub raj mis, Aluminium ntawv ci hnab, 25kg / Cardboard Nruas, los yog raws li tus neeg yuav tsum tau muaj.

Cia txias:Khaws rau hauv cov thawv ntim khoom ntawm qhov chaw txias thiab qhuav;Tiv thaiv los ntawm lub teeb thiab noo noo.

Qhov zoo:

FAQ:

Daim ntawv thov:

6-Methoxyindole (CAS: 3189-13-7) tau siv los kawm txog fluorescence ntawm protonated zoo siab-lub xeev cov ntaub ntawv ntawm serotonin thiab lwm yam sib txuas hauv acid.Nws tau siv rau hauv kev npaj ntawm: tryptophan dioxygenase inhibitors pyridyl-ethenyl-indoles, muaj peev xwm tiv thaiv qog noj ntshav immunomodulator indolylindazoles thiab indolylpyrazolopyridines, interleukin-2 inducible T cell kinase inhibitors diindolyloxyindoles, anticancer agents benzoyl-ethylene-1-diperazinidine inhibitors, cov aroylindoles Raws li anticancer agents indolyl thiab isoquinolinyl anthranilates, PPARδ ib nrab agonists.